rs7014346

This variant is located in the POU5F1B gene.

GWAS Catalog Trait Associations (2)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

colorectal cancer

Allele A
OR 1.19
p 9.0e-26
N 1,983
Large GWAS
multi-ancestry
Zeng C et al. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk. Gastroenterology 150(7):1633-1645 (2016)
Allele A
OR 1.13
p 2.0e-8
N 21,096
Large GWAS
East Asian
Allele A
OR 1.19
p 6.0e-15
N 17,556
Meta-analysisLarge GWAS
European

colon carcinoma

Allele A
OR 1.22
p 4.0e-17
N 414,143
Large GWAS
European

Research that mentions this SNP (1)

Genome-wide investigation of gene–environment interactions in colorectal cancer
AssociationN=1,576Sabine Siegert et al.(2013)· Human Genetics

Genome-wide investigation of gene-environment interactions in colorectal cancer using a two-tiered case-only/case-control design. In 314 sporadic CRC cases (stage I) and 259 familial CRC cases plus 1,002 controls (stage II), rs1944511 showed a significant interaction with overweight (OR=2.00, p=0.042 after multiple testing correction). Several other SNPs showed nominally significant G×E interactions with overweight, smoking, and alcohol consumption. Among candidate CRC-associated SNPs, rs9929218 showed the strongest interaction with alcohol consumption (nominal p=0.008).

Traits studied:Alcohol consumptionColorectal cancerOverweightSmoking

About POU5F1B

This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]

View all POU5F1B variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…